期刊文献+

老年慢性支气管炎采用益肺补肾类中药治疗的临床疗效 被引量:4

Clinical Curative Effect of Traditional Chinese Medicine for Tonifying Lung and Kidney in the treatment of Senile Chronic Bronchitis
下载PDF
导出
摘要 目的探讨采用益肺补肾类中药治疗老年慢性支气管炎的临床疗效。方法选取我院2015年2月至2017年2月收治的82例老年慢性支气管炎患者,随机分为实验组和对照组各41例。对照组采取常规治疗方案,实验组采用益肺补肾类中药治疗。比较两组患者的临床疗效和临床症状消失时间。结果实验组的临床总有效率为92.68%,明显高于对照组的60.98%,差异有统计学意义(P<0.05)。实验组的临床症状消失时间显著短于对照组,差异有统计学意义(P<0.05)。结论益肺补肾类中药应用于老年慢性支气管炎患者,临床疗效显著,能够有效缓解临床症状,缩短临床症状消失时间,安全性较高,值得临床推广。 Objective To explore the clinical curative effect of traditional Chinese medicine for tonifying lung and kidney in the treatment of senile chronic bronchitis. Methods 82 cases of elderly patients with chronic bronchitis admitted to our hospital from February 2015 to February 2017 were selected and randomly divided into experimental group and control group, with 41 cases in each group. The control group received routine treatment, while the experimental group was treated with traditional Chinese medicine for tonifying lung and kidney. The clinical curative effect and disappearance time of clinical symptoms were compared between two groups. Results The clinical total effective rate of experimental group was 92.68%, significantly higher than 60.98% of control group, with statistical difference (P〈0.05). The disappearance time of clinical symptoms of experimental group was significantly shorter than that of control group, with statistical difference (P 〈0.05). Conclusions Traditional Chinese medicine for tonifying lung and kidney in the application of elderly patients with chronic bronchitis can effectively relieve the clinical symptoms and shorten the disappearance time of clinical symptoms with higher safety, which is worthy of clinical promotion.
出处 《临床医学工程》 2017年第11期1571-1572,共2页 Clinical Medicine & Engineering
关键词 老年慢性支气管炎 益肺补肾类中药:临床疗效 Senile chronic bronchitis Tonifying lung and kidney Clinical curative effect
  • 相关文献

二级参考文献29

  • 1屠鹏飞,张红彬,徐国钧,徐珞珊,金蓉鸾.中药沙参类研究──Ⅴ.镇咳祛痰药理作用比较[J].中草药,1995,26(1):22-23. 被引量:34
  • 2张月娥.老年人肺炎38例诊治体会[J].陕西医学杂志,2005,34(9):1173-1174. 被引量:8
  • 3刘广超,吴移谋.肺炎嗜衣原体诊断方法的研究进展[J].微生物学免疫学进展,2006,34(4):71-75. 被引量:9
  • 4陆再英,钟南山.内科学[M].第七版.北京:人民卫生出版社,2008:135-140.
  • 5王吉燿.内科学[M].北京:人民卫生出版社,2006:20.
  • 6Thomas M, File, Jr, et al. The science of selecting antimicrobials for community-acquired pneumonia (CAP) [J]. J Manag Care Pharm, 2009, 15(2): 5-11.
  • 7Campbell LA, Kuo CC. Chlamydia pneumonia infectious risk factor for atherosclerosis[J]. Nat Rev Microbiol, 2004, 2(1): 23-32.
  • 8Boman J, Hammersehlag MR. Chlamydia pneumonia and Atherosclerosis:Critical Assessment of Diagnositic Methods and Relevance to Treatment Studies[J]. Clin Mierobiol Rev, 2002, 15(1): 1-20.
  • 9De Miguel Diez J,García R.J,Hernandez Barrera V. Mental health among adults with asthma and chronic bronchitis.A population-based study in Spain[J].{H}Respiratory Medicine,2012,(07):924-932.
  • 10董学芳,王寿海.咳喘益肺补肾汤治疗老年慢性支气管炎30例[J],实用医院临床杂志,2012,15(7):122-123.

共引文献44

同被引文献28

引证文献4

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部